 | • レポートコード：QYR9ST04164 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、胃腸障害治療薬の世界市場について調査・分析し、胃腸障害治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（過敏性腸症候群（IBS）、慢性便秘（CC）、潰瘍性大腸炎（UC））、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胃腸障害治療薬市場動向 ・主要企業別マーケットシェア ・胃腸障害治療薬の種類別市場規模2014-2019 （過敏性腸症候群（IBS）、慢性便秘（CC）、潰瘍性大腸炎（UC）） ・胃腸障害治療薬の用途別市場規模2014-2019 （病院、診療所、その他） ・胃腸障害治療薬の北米市場：主要企業・種類別/用途別市場規模 ・胃腸障害治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・胃腸障害治療薬の中国市場：主要企業・種類別/用途別市場規模 ・胃腸障害治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・胃腸障害治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・胃腸障害治療薬のインド市場：主要企業・種類別/用途別市場規模 ・胃腸障害治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AstraZeneca、Takeda Pharmaceutical、Johnson & Johnson、Eisai、Abbott Laboratories、Salix Pharmaceuticals、Valeant Pharmaceuticals、Allergan、Bayer、UCB、AbbVie、GlaxoSmithKline、Astellas Pharma） ・胃腸障害治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases.Increasing incidences of gastrointestinal disorders that demands treatment by these therapeutics will boost the growth of this market.
United States is considered to be the largest market of gastrointestinal therapeutics due to the large pool of patients of gastrointestinal disorders
Europe is considered as second largest market of gastrointestinal disorders therapeutics. Efforts of domiciled key players to fill their product pipeline with innovative drugs attracts number of customers and hence drives the market growth.
In 2018, the global Gastrointestinal Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Gastrointestinal Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastrointestinal Disorder Therapeutics development in United States, Europe and China.
The key players covered in this study
AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Valeant Pharmaceuticals
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma
Market segment by Type, the product can be split into
Irritable Bowel Syndrome (IBS)
Chronic Constipation (CC)
Ulcerative Colitis (UC)
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gastrointestinal Disorder Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gastrointestinal Disorder Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gastrointestinal Disorder Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Irritable Bowel Syndrome (IBS)
1.4.3 Chronic Constipation (CC)
1.4.4 Ulcerative Colitis (UC)
1.5 Market by Application
1.5.1 Global Gastrointestinal Disorder Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gastrointestinal Disorder Therapeutics Market Size
2.2 Gastrointestinal Disorder Therapeutics Growth Trends by Regions
2.2.1 Gastrointestinal Disorder Therapeutics Market Size by Regions (2014-2025)
2.2.2 Gastrointestinal Disorder Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gastrointestinal Disorder Therapeutics Market Size by Manufacturers
3.1.1 Global Gastrointestinal Disorder Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gastrointestinal Disorder Therapeutics Key Players Head office and Area Served
3.3 Key Players Gastrointestinal Disorder Therapeutics Product/Solution/Service
3.4 Date of Enter into Gastrointestinal Disorder Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gastrointestinal Disorder Therapeutics Market Size by Type (2014-2019)
4.2 Global Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Gastrointestinal Disorder Therapeutics Market Size (2014-2019)
5.2 Gastrointestinal Disorder Therapeutics Key Players in United States
5.3 United States Gastrointestinal Disorder Therapeutics Market Size by Type
5.4 United States Gastrointestinal Disorder Therapeutics Market Size by Application
6 Europe
6.1 Europe Gastrointestinal Disorder Therapeutics Market Size (2014-2019)
6.2 Gastrointestinal Disorder Therapeutics Key Players in Europe
6.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Type
6.4 Europe Gastrointestinal Disorder Therapeutics Market Size by Application
7 China
7.1 China Gastrointestinal Disorder Therapeutics Market Size (2014-2019)
7.2 Gastrointestinal Disorder Therapeutics Key Players in China
7.3 China Gastrointestinal Disorder Therapeutics Market Size by Type
7.4 China Gastrointestinal Disorder Therapeutics Market Size by Application
8 Japan
8.1 Japan Gastrointestinal Disorder Therapeutics Market Size (2014-2019)
8.2 Gastrointestinal Disorder Therapeutics Key Players in Japan
8.3 Japan Gastrointestinal Disorder Therapeutics Market Size by Type
8.4 Japan Gastrointestinal Disorder Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gastrointestinal Disorder Therapeutics Market Size (2014-2019)
9.2 Gastrointestinal Disorder Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gastrointestinal Disorder Therapeutics Market Size by Type
9.4 Southeast Asia Gastrointestinal Disorder Therapeutics Market Size by Application
10 India
10.1 India Gastrointestinal Disorder Therapeutics Market Size (2014-2019)
10.2 Gastrointestinal Disorder Therapeutics Key Players in India
10.3 India Gastrointestinal Disorder Therapeutics Market Size by Type
10.4 India Gastrointestinal Disorder Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Gastrointestinal Disorder Therapeutics Market Size (2014-2019)
11.2 Gastrointestinal Disorder Therapeutics Key Players in Central & South America
11.3 Central & South America Gastrointestinal Disorder Therapeutics Market Size by Type
11.4 Central & South America Gastrointestinal Disorder Therapeutics Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastrointestinal Disorder Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Takeda Pharmaceutical
12.2.1 Takeda Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastrointestinal Disorder Therapeutics Introduction
12.2.4 Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.2.5 Takeda Pharmaceutical Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastrointestinal Disorder Therapeutics Introduction
12.3.4 Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Eisai
12.4.1 Eisai Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastrointestinal Disorder Therapeutics Introduction
12.4.4 Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.4.5 Eisai Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastrointestinal Disorder Therapeutics Introduction
12.5.4 Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.5.5 Abbott Laboratories Recent Development
12.6 Salix Pharmaceuticals
12.6.1 Salix Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gastrointestinal Disorder Therapeutics Introduction
12.6.4 Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.6.5 Salix Pharmaceuticals Recent Development
12.7 Valeant Pharmaceuticals
12.7.1 Valeant Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gastrointestinal Disorder Therapeutics Introduction
12.7.4 Valeant Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.7.5 Valeant Pharmaceuticals Recent Development
12.8 Allergan
12.8.1 Allergan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gastrointestinal Disorder Therapeutics Introduction
12.8.4 Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.8.5 Allergan Recent Development
12.9 Bayer
12.9.1 Bayer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gastrointestinal Disorder Therapeutics Introduction
12.9.4 Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.9.5 Bayer Recent Development
12.10 UCB
12.10.1 UCB Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gastrointestinal Disorder Therapeutics Introduction
12.10.4 UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)
12.10.5 UCB Recent Development
12.11 AbbVie
12.12 GlaxoSmithKline
12.13 Astellas Pharma
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Gastrointestinal Disorder Therapeutics Key Market Segments
Table Key Players Gastrointestinal Disorder Therapeutics Covered
Table Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type 2014-2025
Figure Irritable Bowel Syndrome (IBS) Figures
Table Key Players of Irritable Bowel Syndrome (IBS)
Figure Chronic Constipation (CC) Figures
Table Key Players of Chronic Constipation (CC)
Figure Ulcerative Colitis (UC) Figures
Table Key Players of Ulcerative Colitis (UC)
Table Global Gastrointestinal Disorder Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Gastrointestinal Disorder Therapeutics Report Years Considered
Table Global Gastrointestinal Disorder Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Gastrointestinal Disorder Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gastrointestinal Disorder Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Gastrointestinal Disorder Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Gastrointestinal Disorder Therapeutics Market Share by Regions 2014-2019
Figure Global Gastrointestinal Disorder Therapeutics Market Share by Regions 2014-2019
Figure Global Gastrointestinal Disorder Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Gastrointestinal Disorder Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gastrointestinal Disorder Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Gastrointestinal Disorder Therapeutics Market Share by Manufacturers in 2018
Table Global Gastrointestinal Disorder Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gastrointestinal Disorder Therapeutics Product/Solution/Service
Table Date of Enter into Gastrointestinal Disorder Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gastrointestinal Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Gastrointestinal Disorder Therapeutics Market Size Share by Type (2014-2019)
Figure Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Gastrointestinal Disorder Therapeutics Market Size Share by Application (2014-2019)
Figure Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Application in 2018
Figure United States Gastrointestinal Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Gastrointestinal Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Gastrointestinal Disorder Therapeutics Market Share (2018-2019)
Table United States Gastrointestinal Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Gastrointestinal Disorder Therapeutics Market Share by Type (2014-2019)
Table United States Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Gastrointestinal Disorder Therapeutics Market Share by Application (2014-2019)
Figure Europe Gastrointestinal Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Gastrointestinal Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Gastrointestinal Disorder Therapeutics Market Share (2018-2019)
Table Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Gastrointestinal Disorder Therapeutics Market Share by Type (2014-2019)
Table Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Gastrointestinal Disorder Therapeutics Market Share by Application (2014-2019)
Figure China Gastrointestinal Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Gastrointestinal Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Gastrointestinal Disorder Therapeutics Market Share (2018-2019)
Table China Gastrointestinal Disorder Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Gastrointestinal Disorder Therapeutics Market Share by Type (2014-2019)
Table China Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Gastrointestinal Disorder Therapeutics Market Share by Application (2014-2019)
Figure Japan Gastrointestinal Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Gastrointestinal Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Gastrointestinal Disorder Therapeutics Market Share (2018-2019)
Table Japan Gastrointestinal Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Gastrointestinal Disorder Therapeutics Market Share by Type (2014-2019)
Table Japan Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Gastrointestinal Disorder Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Gastrointestinal Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gastrointestinal Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gastrointestinal Disorder Therapeutics Market Share (2018-2019)
Table Southeast Asia Gastrointestinal Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gastrointestinal Disorder Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gastrointestinal Disorder Therapeutics Market Share by Application (2014-2019)
Figure India Gastrointestinal Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Gastrointestinal Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Gastrointestinal Disorder Therapeutics Market Share (2018-2019)
Table India Gastrointestinal Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Gastrointestinal Disorder Therapeutics Market Share by Type (2014-2019)
Table India Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Gastrointestinal Disorder Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Gastrointestinal Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gastrointestinal Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gastrointestinal Disorder Therapeutics Market Share (2018-2019)
Table Central & South America Gastrointestinal Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Disorder Therapeutics Market Share by Type (2014-2019)
Table Central & South America Gastrointestinal Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Disorder Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Eisai Company Details
Table Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table Eisai Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Salix Pharmaceuticals Company Details
Table Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table Salix Pharmaceuticals Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Allergan Company Details
Table Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table Bayer Company Details
Table Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table UCB Company Details
Table UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2014-2019)(Million US$)
Figure UCB Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2014-2019)
Table UCB Recent Development
Table AbbVie Company Details
Table GlaxoSmithKline Company Details
Table Astellas Pharma Company Details
Table Global Gastrointestinal Disorder Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Gastrointestinal Disorder Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Gastrointestinal Disorder Therapeutics Market Size Share by Regions in 2025
Figure United States Gastrointestinal Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gastrointestinal Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Gastrointestinal Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gastrointestinal Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gastrointestinal Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Gastrointestinal Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gastrointestinal Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Gastrointestinal Disorder Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Gastrointestinal Disorder Therapeutics Market Size by Product (2019-2025)
Figure Global Gastrointestinal Disorder Therapeutics Market Size by Product in 2025
Table Global Gastrointestinal Disorder Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Gastrointestinal Disorder Therapeutics Market Size by Application (2019-2025)
Figure Global Gastrointestinal Disorder Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
胃腸治療薬の世界市場：市場規模・現状・予測 Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarr…- 自閉症スペクトラム障害診断及び治療の世界市場：市場規模・現状・予測 Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Over the past few years, with the increased number of infants an…
- 双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…
- 注意欠陥多動性障害（ADHD）治療薬の世界市場：市場規模・現状・予測 ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning. …
- 慢性閉塞性肺疾患の世界市場：市場規模・現状・予測 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.The…